Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-21-020483

Chief Medical Officer sold 1,000 shares at an average $64.56 ($64,556)

  • Chief Medical Officer acquired 1,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ordonez Claudia Chief Medical Officer 2021-03-11 Option exercise +1,000 $0.48 $480 1,000 D: show line 1 in the form
Ordonez Claudia Chief Medical Officer 2021-03-11 Sale −395 $64.09 $25,316 605 D: show line 2 in the form
Ordonez Claudia Chief Medical Officer 2021-03-11 Sale −605 $64.86 $39,240 0 D: show line 3 in the form
Open-market sales · 1,000 sh · avg $64.56 · $64,556

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ordonez Claudia Chief Medical Officer 2021-03-11 Option exercise · Employee Stock Option (right to buy) −1,000 101,211 D: show line 4 in the form
Loading xslF345X03/doc4.xml…